医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

广告
第一作者: Zhong, Wen-Zhao
作者单位: Suzhou Univ, Affiliated Hosp 1, Suzhou, Peoples R China [1] Peking Univ First Hosp, Beijing, Peoples R China [2] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China [3] Jiangsu Canc Hosp, Nanjing, Peoples R China [4] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou 510080, Peoples R China [5] Sichuan Univ, West China Hosp, Chengdu, Peoples R China [6] Fudan Univ, Affiliated Zhongshan Hosp, Shanghai, Peoples R China [7] Jilin Prov Tumor Hosp, Changchun, Peoples R China [8] Shanghai Pulm Hosp, Shanghai, Peoples R China [9] Northern Jiangsu Peoples Hosp, Yangzhou, Jiangsu, Peoples R China [10] Zhejiang Canc Hosp, Hangzhou, Peoples R China [11] Peking Univ, Peoples Hosp, Beijing, Peoples R China [12] China Med Univ, Hosp 1, Shenyang, Peoples R China [13] Shenyang Chest Hosp, Shenyang, Peoples R China [14] Tangdu Hosp, Xian, Peoples R China [15] Fujian Canc Hosp, Fuzhou, Peoples R China [16] Beijing Chest Hosp, Beijing, Peoples R China [17] Sichuan Canc Hosp, Chengdu, Peoples R China [18] Beijing Canc Hosp, Beijing, Peoples R China [19] Hunan Canc Hosp, Changsha, Peoples R China [20] Qingdao Univ, Affiliated Hosp, Med Coll, Qingdao, Peoples R China [21] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [22]
发布时间 2021-05-08
提交
  • 浏览9
Journal of Clinical Oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷